The prospective study looked at 77 patients undergoing ALIF procedures with the device. Independent radiologists analyzed the 138 spine segment levels treated, and found a 100 percent fusion rate between 6 and 12 months, according to the release.
The Endoskeleton implant uses a proprietary acid-etched surface to support bone purchase and new bone growth.
More Articles on Devices:
Medtronic to Recruit 323 Patients for Back Pain Treatment Clinical Trial
Medical Device Purchase: 3 Statistics on Physician Influence
FDA Increases Stryker Knee Device Recall to Class 1
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.